| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Iovance Biotherapeutics (NASDAQ:IOVA) through any online brokerage.
Other companies in Iovance Biotherapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Iovance Biotherapeutics has a consensus price target of $12.21.
The stock price for Iovance Biotherapeutics (NASDAQ: IOVA) is $14.11 last updated October 5, 2026 at 7:37 PM EDT.
There are no upcoming dividends for Iovance Biotherapeutics.
Iovance Biotherapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Iovance Biotherapeutics.
Iovance Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
